If you suffered losses exceeding $75,000 in Nextracker between February 1, 2024 and August 1, 2024 and would like to discuss ...

If you suffered losses exceeding $50,000 in Lilium between June 11, 2024 and November 3, 2024 and would like to discuss your ...

If you suffered losses exceeding $50,000 in Aehr between January 9, 2024 and March 24, 2024 and would like to discuss your ...

If you suffered losses exceeding $50,000 in ASP Isotopes between October 30, 2024 and November 26, 2024 and would like to ...

If you suffered losses exceeding $50,000 in Marqeta between May 7, 2024 and November 4, 2024 and would like to discuss your ...

If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Nextracker To Contact Him Directly To Discuss Their Options If you ...

If you suffered losses exceeding $50,000 in Applied Therapeutics January 3, 2024 and December 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...

On June 2, 2024, Caribou issued a press release announcing that it had "presented updated clinical data from the ongoing ANTLER Phase 1 trial that [purportedly] indicates a single dose of CB-010 . . .

If you suffered losses exceeding $75,000 in Transocean between October 31, 2023 and September 2, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...

If you suffered losses exceeding $75,000 in DMC between May 3, 2024 and November 4, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 ...

On September 25, 2024, Blue Orca Capital published a report alleging, among other things, that Sun Communities' CEO "received an undisclosed $4 million loan from the family of a purportedly ...